Canadian Rheumatology Association (CRA) Meeting, Quebec City, Quebec, February 3-6, 2010

医学 痹症科 内科学 家庭医学
出处
期刊:The Journal of Rheumatology [The Journal of Rheumatology Publishing Company Limited]
卷期号:37 (6): 1271-1354 被引量:3
标识
DOI:10.3899/jrheum.100360
摘要

Objective: A number of outcome measures to assess disease activity in SLE patients have been developed.SLEDAI-2K (Systemic Lupus Erythematosus Activity Index-2K) is a reliable valid, simple, one-page activity index recording features of active lupus as present or not present.Thus its utility in clinical trials is limited as it cannot reflect partial improvement in a disease manifestation.The objective of this study is to develop a SLEDAI-2K responder measure which could document a minimum 50% improvement in disease manifestations among lupus patients.Methods: Derivation of SRI-50 (SLEDAI-2K Responder Index-50) from SLEDAI-2K: A new definition for each of the original descriptors of SLEDAI-2K was created to reflect a minimum improvement of 50%.The definitions of descriptors of SRI-50 were constructed based on a literature review for each specific organ system.The new assigned scores for the descriptors of SRI-50 were derived by dividing the score of SLEDAI-2K by 2. Assessing the content validity of the draft instruments: SRI-50 form was assessed by expert rheumatologists reviewing the instruments and providing critical feedback.Results: Testing of SRI-50: One hundred patients who had experienced lupus flares or had persistently active disease were assessed initially and then reassessed after treatment was initiated.SLEDAI-2K was determined on the first visit and again at the second visit along with SRI-50.Results: SRI-50 and the data retrieval form to accurately document the clinical and laboratory findings of each descriptor were developed.Seventy two patients didn't change their SRI-50 because their manifestations resolved or didn't meet the definition of SRI-50 Twenty eight patients with varying levels of disease activity at the first visit (3 had SLEDAI-2K 2, 3 had 4; 6 had 6; 6 had 8; 3 had 10; 2 had 12; 1 had 16, 1 had 18; 2 had 20; 1 had 21) were further studied with SRI-50.SRI-50 was able to demonstrate incomplete (but ≥50%) improvement which would not have been discerned using SLEDAI-2K.Such incomplete improvement was demonstrated in 13 of the 24 SLEDAI-2K descriptors and in 6 of the 9 organ systems that were present in these patients.Conclusion: SLEDAI-2K Responder Index-50 is a promising instrument that can describe partial improvement in disease activity between visits in lupus patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wrr完成签到,获得积分10
刚刚
wanci应助武雨寒采纳,获得10
1秒前
AHA发布了新的文献求助10
2秒前
顾矜应助WLWLW采纳,获得10
2秒前
CipherSage应助澡雪采纳,获得10
2秒前
HanFeiZi完成签到 ,获得积分10
3秒前
爱听歌的大地完成签到 ,获得积分10
5秒前
阳光的紊应助lingua采纳,获得200
8秒前
Akim应助靖哥哥采纳,获得10
9秒前
10秒前
我是老大应助英勇的寒蕾采纳,获得10
10秒前
10秒前
李爱国应助研友_8op5gL采纳,获得10
11秒前
11秒前
顺利的白山完成签到 ,获得积分10
11秒前
15秒前
15秒前
youyou发布了新的文献求助10
15秒前
zhzssaijj完成签到,获得积分10
15秒前
FunHigh发布了新的文献求助10
17秒前
17秒前
17秒前
武雨寒发布了新的文献求助10
19秒前
19秒前
gettttting完成签到,获得积分10
19秒前
wwhhgg11发布了新的文献求助10
20秒前
23秒前
lulu完成签到,获得积分10
23秒前
桐桐应助周常通采纳,获得10
23秒前
wwhhgg11完成签到,获得积分10
26秒前
呱gua发布了新的文献求助10
26秒前
刘一安完成签到 ,获得积分10
27秒前
27秒前
英勇的寒蕾完成签到,获得积分10
27秒前
28秒前
29秒前
OKOK发布了新的文献求助10
29秒前
锦瑟完成签到 ,获得积分10
29秒前
科研通AI5应助mt1314采纳,获得10
30秒前
Kombate发布了新的文献求助10
31秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975814
求助须知:如何正确求助?哪些是违规求助? 3520123
关于积分的说明 11201020
捐赠科研通 3256502
什么是DOI,文献DOI怎么找? 1798347
邀请新用户注册赠送积分活动 877523
科研通“疑难数据库(出版商)”最低求助积分说明 806417